Friday, June 3, 2016, 90 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $3.36 to $12,830,365.80.

Highlighted Stocks Traded by Insiders:

TICC Capital (TICC) - FREE Research Report

Rosenthal Saul B, who is President and COO at TICC Capital, bought 174,640 shares at $5.64 on June 3, 2016. Following this transaction, the President and COO owned 635,595 shares meaning that the stake was boosted by 37.89% with the 174,640-share transaction.

Cohen Jonathan H, who is Chief Executive Officer at TICC Capital, bought 174,640 shares at $5.64 on June 3, 2016. Following this transaction, the Chief Executive Officer owned 838,458 shares meaning that the stake was boosted by 26.31% with the 174,640-share transaction.

The shares most recently traded at $5.67, up $0.03, or 0.6% since the insider transaction. Historical insider transactions for TICC Capital go as follows:

  • 4-Week # shares bought: 777,747
  • 12-Week # shares bought: 883,447
  • 24-Week # shares bought: 883,447

The average volume for TICC Capital has been 227,600 shares per day over the past 30 days. TICC Capital has a market cap of $288.3 million and is part of the financial sector and financial services industry. Shares are down 6.91% year-to-date as of the close of trading on Friday.

TICC Capital Corp. is a business development company, operates as a closed-end, non-diversified management investment company. The firm invests in both public and private companies. The stock currently has a dividend yield of 20.71%. The company has a P/E ratio of 8.4. Currently, there is 1 analyst who rates TICC Capital a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TICC - FREE

TheStreet Quant Ratings

rates TICC Capital as a

hold

. The company's strengths can be seen in multiple areas, such as its good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and a generally disappointing performance in the stock itself. Get the full

TICC Capital Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Maxim Integrated Products (MXIM) - FREE Research Report

Jain Vivek, who is Senior Vp at Maxim Integrated Products, sold 390 shares at $37.80 on June 3, 2016. Following this transaction, the Senior Vp owned 66,725 shares meaning that the stake was reduced by 0.58% with the 390-share transaction.

The shares most recently traded at $37.86, up $0.06, or 0.17% since the insider transaction. Historical insider transactions for Maxim Integrated Products go as follows:

  • 4-Week # shares sold: 6,042
  • 12-Week # shares sold: 12,185
  • 24-Week # shares sold: 91,025

The average volume for Maxim Integrated Products has been 1.9 million shares per day over the past 30 days. Maxim Integrated Products has a market cap of $10.9 billion and is part of the technology sector and electronics industry. Shares are down 0.29% year-to-date as of the close of trading on Friday.

Maxim Integrated Products, Inc. designs, develops, manufactures, and markets various linear and mixed-signal integrated circuits worldwide. The company also provides a range of high-frequency process technologies and capabilities for use in custom designs. The stock currently has a dividend yield of 3.14%. The company has a P/E ratio of 47.1. Currently, there are 9 analysts who rate Maxim Integrated Products a buy, 3 analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MXIM - FREE

TheStreet Quant Ratings

rates Maxim Integrated Products as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, compelling growth in net income, expanding profit margins, largely solid financial position with reasonable debt levels by most measures and impressive record of earnings per share growth. We feel its strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full

Maxim Integrated Products Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

HMS Holdings (HMSY) - FREE Research Report

Neuman Semone, who is EVP, Operations at HMS Holdings, sold 5,124 shares at $17.60 on June 3, 2016. Following this transaction, the EVP, Operations owned 106,200 shares meaning that the stake was reduced by 4.6% with the 5,124-share transaction.

The shares most recently traded at $17.82, up $0.22, or 1.23% since the insider transaction. Historical insider transactions for HMS Holdings go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 10,000
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 10,000
  • 24-Week # shares bought: 2,000
  • 24-Week # shares sold: 76,992

The average volume for HMS Holdings has been 634,900 shares per day over the past 30 days. HMS Holdings has a market cap of $1.5 billion and is part of the services sector and diversified services industry. Shares are up 43.35% year-to-date as of the close of trading on Friday.

HMS Holdings Corp., through its subsidiaries, operates in the healthcare insurance benefit cost containment market in the United States. The company has a P/E ratio of 62.2. Currently, there are 8 analysts who rate HMS Holdings a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on HMSY - FREE

TheStreet Quant Ratings

rates HMS Holdings as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. Get the full

HMS Holdings Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.